| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |